COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Autologous Bone Marrow Mononuclear Cells in the Combined Treatment of Coronary Heart Disease (TAMIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02059512
Recruitment Status : Unknown
Verified December 2016 by St. Petersburg State Pavlov Medical University.
Recruitment status was:  Active, not recruiting
First Posted : February 11, 2014
Last Update Posted : September 28, 2017
Information provided by (Responsible Party):
St. Petersburg State Pavlov Medical University

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Actual Primary Completion Date : December 2016
Estimated Study Completion Date : February 2018
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 March 27, 2018
(Canceled - Date Unknown)
March 30, 2018
(Canceled on July 17, 2018)
August 17, 2018
(Canceled on September 23, 2018)
September 23, 2018
February 12, 2019
2 April 8, 2019
June 28, 2019
3 July 29, 2020
August 14, 2020
4 October 21, 2020
November 13, 2020
5 January 11, 2021